Population pharmacokinetic model-predicted mean dinaciclib exposure ( area under the concentration-time curve extrapolated to infinity -LSB- AUC -LSB- I -RSB- -RSB- ) at @ mg/m ( @ ) was similar to that observed in a previous phase I trial , and no drug accumulation was observed after multiple-dose administration .